EPIC | SCLP |
Sector | Pharma and Biotech |
ISIN | GB00B63D3314 |
Market Sector | AIM |
Market Segment | ASQ1 |
Main Indices | FTSE AIM All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £134.56m |
NMS | 20,000 |
Shares in issue | 927.98m |
Date Listed | 30-Jul-2010 |
Currency | UK Pounds |
Share Price | 14.50p |
Change Today | -0.50p |
% Change | -3.33 % |
52 Week High | 19.50 |
52 Week Low | 8.92 |
Volume | 601,540 |
Shares Issued | 927.98m |
Market Cap | £134.56m |
Beta | 0.49 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:29 | 100 @ 14.11p |
16:24 | 46 @ 14.00p |
16:23 | 50,285 @ 14.31p |
15:24 | 30,000 @ 14.50p |
15:23 | 50,000 @ 14.50p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research